rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

FitLife Brands, Inc.

FTLF · Nasdaq

Health CarePharmaceuticalsNot moving yet

FTLF stood above a rising 150-day average in 9 of the last 52 weekly readings, and has been out of that trend for the last 43 weeks. It is 19.6% below that average now. Pharmaceuticals: 32% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 43
Industry in uptrend
32% -7 in 4 wk
Insider buys, 12 months
$147K
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
43 (+2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 9 of 52 weeks.

20 Apr – 19 Oct
26%34%43%Apr 26Jun 26Jul 26Sep 26Oct 26

Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$114KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months5
Sale orders, 12 months0
Buyers · sellers4 · 0
WhoDidSharesTraded
Shannon K. PappasDirectorbought1,000at $10.2519 Aug 2026filed 21 Aug 2026
Grant Robert DawsonDirectorbought3,000at $9.9810 Apr 2026filed 14 Apr 2026
Matthew LingenbrinkDirectorbought3,000at $9.7610 Apr 2026filed 14 Apr 2026
Seth YakatanDirectorbought164at $15.3615 Jan 2026filed 20 Apr 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders43+2 on the quarter
New · exited15 · 13
Reported value$7.1M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026154,255$1.7M-352−0.2%
HORIZON KINETICS ASSET MANAGEMENT LLCreduced · filed 11 Aug 2026145,000$1.6M-9,456−6.1%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 202649,045$540K-38,632−44.1%
Mink Brook Asset Management LLCadded · filed 14 Aug 202646,637$513K+17,993+62.8%
BlackRock, Inc.reduced · filed 7 Aug 202635,275$388K-122,129−77.6%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 202626,219$289K+1,277+5.1%
MILLENNIUM MANAGEMENT LLCnew · filed 14 Aug 202623,453$258K+23,453
Mariner, LLCnew · filed 13 Aug 202622,006$242K+22,006
BARD ASSOCIATES INCadded · filed 12 Aug 202621,177$233K+1,211+6.1%
SUSQUEHANNA INTERNATIONAL GROUP, LLPnew · filed 14 Aug 202618,005$198K+18,005
30 Sep 2023 – 30 Jun 2026
32342Sep 23Jun 24Mar 25Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Jakob York Company insiderCHIEF FINANCIAL OFFICER · last 28 Aug 20261 · 0
Shannon K. Pappas Company insiderDirector · last 19 Aug 20261 · 0
Ryan P. Hansen Company insiderPresident · last 15 May 20260 · 0
Grant Robert Dawson Company insiderDirector · last 10 Apr 20261 · 0
Matthew Lingenbrink Company insiderDirector · last 10 Apr 20263 · 0
Seth Yakatan Company insiderDirector · last 15 Jan 20264 · 0
Todd Ordal Company insiderDirector · last 15 Apr 20252 · 1
Judd Dayton Company insiderCHIEF EXECUTIVE OFFICER · last 31 Mar 202551 · 0
Patrick John Phillip Ryan Company insiderCHIEF RETAIL OFFICER · last 3 Jun 20240 · 3
Susan Kinnaman Company insiderCHIEF FINANCIAL OFFICER · last 16 Apr 20210 · 0
Lewis Jaffe Company insiderDirector · last 16 Oct 20200 · 1
Michael S. Abrams Company insiderCHIEF FINANCIAL OFFICER · last 16 Jan 20162 · 0

Same industry

ABBV AbbVieLeading+19%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202538.6%
Operating profit marginFY 2025 · to 31 Dec 202512.4%
Free cash flow marginFY 2025 · to 31 Dec 20259.1%
Return on capital employedFY 2025 · to 31 Dec 202511.9%
Cash conversionFY 2025 · to 31 Dec 2025118%
Share count trendFY 2025 · to 27 Mar 20260.0%
Free cash flowFY 2025 · to 31 Dec 2025$7.4M

Analyst forecasts

No analyst forecasts yet.